PharmaVoice
FEBRUARY 24, 2025
Health agency job cuts and a newly-established MAHA commission leave many unanswered questions about potential reforms and impact on drug approvals.
MedCity News
FEBRUARY 24, 2025
The HRT Club provides access to a network of over 700 healthcare providers who can prescribe hormone replacement therapies. The post The HRT Club Launches to Expand Access to Hormonal Care appeared first on MedCity News.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare Success
FEBRUARY 24, 2025
This week's podcast dives into successful sales leadership and is relevant to most healthcare verticals, including B2B sales in SaaS, pharmaceuticals, medical device, hospitals, etc. It also applies to high-value B2C sales, e.g., elective surgeries, orthodontics, senior care, and residential treatment centers. My guest, Chris Jennings , CEO of Chris Jennings Group , reveals the essential traits of successful healthcare sales leadership.
European Pharmaceutical Review
FEBRUARY 24, 2025
The UKs National Institute For Health And Care Excellence (NICE) has recommended an innovative combination immunotherapy for use on the NHS. The therapy is indicated for individuals with the blood cancer called acute lymphoblastic leukaemia (ALL). As a bispecific T-cell engager (BiTE) therapy, Blincyto (blinatumomab) provides a new treatment approach, helping the immune system to recognise and eliminate residual cancer cells following initial treatment.
Advertiser: ZoomInfo
AI adoption is reshaping sales and marketing. But is it delivering real results? We surveyed 1,000+ GTM professionals to find out. The data is clear: AI users report 47% higher productivity and an average of 12 hours saved per week. But leaders say mainstream AI tools still fall short on accuracy and business impact. Download the full report today to see how AI is being used — and where go-to-market professionals think there are gaps and opportunities.
Pharmaceutical Technology
FEBRUARY 24, 2025
With Novo Nordisks blockbuster drugs Wegovy and Ozempic back in stock, copycat versions are no longer allowed for now.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
Pharmaceutical Technology
FEBRUARY 24, 2025
PHARMAP 2025 takes place on 14-15 April 2025 in Berlin, Germany.
pharmaphorum
FEBRUARY 24, 2025
The FDA has started a priority review of Bristol Myers Squibb's Opdivo and Yervoy as first-line therapy for MSI-H and dMMR colorectal cancer
Pharmaceutical Technology
FEBRUARY 24, 2025
In an anonymous post in the BMJ, the author claims that words relating to DEI could lead to grants being taken away.
pharmaphorum
FEBRUARY 24, 2025
Mirum Pharma's Ctexli has become the first FDA-approved therapy for ultra-rare disease cerebrotendinous xanthomatosis (CTX)
Speaker: Jesse Hunter and Brynn Chadwick
Today’s buyers expect more than generic outreach–they want relevant, personalized interactions that address their specific needs. For sales teams managing hundreds or thousands of prospects, however, delivering this level of personalization without automation is nearly impossible. The key is integrating AI in a way that enhances customer engagement rather than making it feel robotic.
Pharmaceutical Technology
FEBRUARY 24, 2025
MeiraGTxs investigational gene therapy AAV-AIPL1 has improved the sight of 11 children who were born blind.
pharmaphorum
FEBRUARY 24, 2025
At risk of defaulting on financial commitments, gene therapy firm bluebird bio has agreed to sell itself to private equity firms at a knockdown price.
Pharmaceutical Technology
FEBRUARY 24, 2025
Celltrion has secured marketing authorisation from the EC for Avtozma, a biosimilar to Chugai Pharmaceuticals RoActemra (tocilizumab).
pharmaphorum
FEBRUARY 24, 2025
The FDA has said there is no longer a shortage in the US market for Novo Nordisk's GLP-1 agonist semaglutide, ending sales of compounded forms.
Advertiser: ZoomInfo
ZoomInfo customers aren’t just selling — they’re winning. Revenue teams using our Go-To-Market Intelligence platform grew pipeline by 32%, increased deal sizes by 40%, and booked 55% more meetings. Download this report to see what 11,000+ customers say about our Go-To-Market Intelligence platform and how it impacts their bottom line. The data speaks for itself!
PharmaTech
FEBRUARY 24, 2025
Cerebrotendinous xanthomatosis, or CTX, is a metabolic disorder caused by a gene mutation that results in a deficiency of an important enzyme in the ability of the human body to break down fats.
Pharmaceutical Commerce
FEBRUARY 24, 2025
The latest news for pharma industry insiders.
Pharmaceutical Technology
FEBRUARY 24, 2025
Teva Pharmaceuticals and Alvotech have announced the US launch of Selarsdi (ustekinumab-aekn) injection, a biosimilar to J&Js Stelara.
Pharmaceutical Commerce
FEBRUARY 24, 2025
In the first part of his video interview with Pharma Commerce Editor Nicholas Saraceno, Tom Dorsett, CEO, RazorMetrics, explains the concept of polypharmacy, including how prominent it is in the United States today.
Speaker: Kevin Burke
AI is reshaping marketing and sales, empowering professionals to work smarter, faster, and more effectively. This webinar will provide a practical introduction to AI, focusing on its current applications, transformative potential, and strategies for successful implementation in your organization. Using real-world examples and actionable insights, we’ll examine how businesses are leveraging AI to increase efficiency, enhance personalization, and drive measurable results.
Pharmaceutical Technology
FEBRUARY 24, 2025
Mirum Pharmaceuticals Ctexli (chenodiol) has gained US Food and Drug Administration (FDA) approval for treating adults with CTX.
Pharmacy Times
FEBRUARY 24, 2025
The FDAs accelerated approval of lifileucel (Amtagvi; Iovance Biotherapeutics) marks a major milestone in immunotherapy for metastatic melanoma, building on decades of research in tumor-infiltrating lymphocyte therapy.
PharmaTech
FEBRUARY 24, 2025
More and more contract manufacturers have been looking not at what the state of the supply chain is right now, but what it may be in the next three to five years.
PharmExec
FEBRUARY 24, 2025
The BrainSense adaptive deep brain stimulation system personalizes therapy by dynamically adjusting stimulation based on real-time brain activity to improve Parkinson disease symptom control without manual adjustments.
Advertiser: ZoomInfo
Incorporating generative AI (gen AI) into your sales process can speed up your wins through improved efficiency, personalized customer interactions, and better informed decision- making. Gen AI is a game changer for busy salespeople and can reduce time-consuming tasks, such as customer research, note-taking, and writing emails, and provide insightful data analysis and recommendations.
Pharmaceutical Commerce
FEBRUARY 24, 2025
The injection for the treatment of psoriatic arthritisamong other indicationsis a biosimilar to Stelara.
PharmExec
FEBRUARY 24, 2025
Launching this month, Vaxitek HVT+IBD+H5 integrates COBRA technology to address the ongoing viral evolution challenges of avian influenza, as well as for the prevention of Marek disease and infectious bursal disease.
pharmaphorum
FEBRUARY 24, 2025
Pfizer has abandoned its haemophilia B treatment Beqvez in all world markets, saying weak demand made the business non-viable.
PharmExec
FEBRUARY 24, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Advertisement
What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.
Pharmacy Times
FEBRUARY 24, 2025
Advancements in neoantigen vaccines and immunotherapy are transforming cancer treatment by leveraging genomic sequencing to overcome tumor heterogeneity and therapeutic resistance.
PharmExec
FEBRUARY 24, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmacy Times
FEBRUARY 24, 2025
Immunotherapy pioneer James P. Allison, PhD, revolutionized cancer treatment by discovering immune checkpoint blockade, leading to significant advances in survival rates and ongoing efforts to optimize immuno-oncology strategies.
Expert insights. Personalized for you.
259 
Let's personalize your content